BMG PHARMA S.P.A.

BMG Pharma is an Italian pharmaceutical company with expertise in the development of new products in several therapeutic areas. From prevention to treatment, BMG transforms scientific innovation into healthcare solutions in cancer supportive care, dermatology, oral care, osteoarthritis & women's health. Relying on its strong portfolio of intellectual property, BMG has developed numerous products to address specific needs in these areas through its partners. The company recently acquired Sigea, an Italian company with expertise in targeted functional ingredients development specifically focused on modified Sodium Hyaluronate. This allows BMG to address demands in therapeutic areas such as dermatology and oral care with superior products. We are dedicated to partnering our products with distributors around the world and working with them to ensure our products reach those who rely on us.